Global Anti-worm Medication Market Size By Type (Albenza, Vermox), By Application (Human , Veterinary), By Region, And Segment Forecasts, 2023 to 2032

The Global Anti-worm Medication Market was valued at USD 2.4 billion in 2023 and is projected to reach USD 4.1 billion by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. The market is primarily driven by the increasing prevalence of parasitic infections, rising awareness of hygiene and health, and expanded government deworming initiatives in low- and middle-income countries. Anti-worm medications, also known as anthelmintics, play a crucial role in combating helminthic infections in humans and animals, especially in regions with inadequate sanitation infrastructure.

The growing demand for over-the-counter (OTC) treatments and the continuous innovation of broad-spectrum and pediatric-friendly formulations are expected to boost market growth globally.

Drivers:

1. Rising Incidence of Parasitic Infections:

Soil-transmitted helminths (STH), schistosomiasis, and other worm infections continue to affect millions worldwide, especially in tropical and subtropical regions. This rising disease burden is pushing for broader distribution and consumption of anti-worm medications.

2. Government-Led Deworming Programs:

Many countries are running large-scale mass drug administration (MDA) campaigns targeting school-age children and vulnerable populations. WHO-led initiatives and partnerships with pharmaceutical firms have accelerated access to essential anthelmintic drugs.

3. Increasing Pet Ownership and Livestock Health Awareness:

The surge in pet adoption and rising awareness regarding zoonotic diseases is fueling demand for veterinary anti-worm medications. Moreover, the livestock sector's focus on parasite control for animal health and productivity is also contributing to market growth.

Restraints:

1. Drug Resistance Concerns:

Prolonged and widespread use of certain anthelmintic drugs has led to growing resistance, particularly in livestock and veterinary applications. This reduces drug efficacy and necessitates more frequent treatments or combination therapies.

2. Limited Access in Remote Areas:

Despite efforts from global health bodies, access to anti-worm medications remains limited in remote or impoverished regions due to weak health infrastructure and supply chain constraints.

Opportunity:

1. Development of Novel Drug Formulations:

There is a growing focus on developing long-acting, palatable, and pediatric-specific drug formulations that improve compliance and therapeutic outcomes. Companies are also investing in novel drug delivery mechanisms, including chewables and liquid suspensions.

2. Untapped Emerging Markets:

Emerging economies in Sub-Saharan Africa, Southeast Asia, and parts of Latin America offer significant growth potential due to high worm disease burden, rising public health investments, and improving awareness.

3. Veterinary Health Expansion:

The global growth of the veterinary pharmaceutical sector offers new opportunities for anti-worm medication manufacturers, particularly for pets and livestock industries in developed and rapidly developing nations.

Market by System Type Insights:

Based on product type, Broad-spectrum anti-worm medications accounted for the largest market share in 2023. These medications, such as albendazole and mebendazole, are widely used due to their effectiveness against multiple types of worms and high safety profile. The segment is expected to maintain dominance due to its role in mass deworming programs and OTC accessibility.

Target-specific medications (e.g., praziquantel for schistosomiasis) are also gaining traction, particularly in endemic regions, and are anticipated to grow rapidly during the forecast period.

Market by End-use Insights:

In terms of end-use, the Human Healthcare segment led the market in 2023, driven by widespread need in public health programs and retail pharmacy sales. Deworming initiatives in school children, rising personal healthcare awareness, and increasing OTC availability have fueled this segment’s dominance.

The Veterinary segment is projected to experience the fastest growth, fueled by growing pet ownership, livestock disease control measures, and veterinary wellness trends globally.

Market by Regional Insights:

Asia-Pacific dominated the global anti-worm medication market in 2023, accounting for the largest share due to its high disease burden, extensive deworming programs, and a large rural population. India, China, and Southeast Asian countries are key contributors.

Africa is expected to witness the highest CAGR during the forecast period due to WHO support, government partnerships, and increasing healthcare access.

North America and Europe also hold significant shares, driven by strong veterinary care markets and rising public health awareness.

Competitive Scenario:

Key players in the global anti-worm medication market include GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Bayer AG, Sanofi, Cadila Pharmaceuticals, Cipla Ltd., Merck & Co., Inc., Zoetis Inc., and Elanco Animal Health.

These companies are investing in R&D for improved formulations, expanding their product portfolios, and engaging in collaborations with government and nonprofit organizations to support deworming initiatives.

Scope of Work – Global Anti-worm Medication Market

Report Metric Details

Market Size (2023) USD 2.4 billion

Projected Market Size (2031) USD 4.1 billion

CAGR (2023-2031) 6.9%

Market Segments By System Type (Broad-spectrum, Target-specific), By End-use (Human, Veterinary), By Region

Growth Drivers Rising incidence of parasitic infections, Government-led deworming programs, Pet and livestock health awareness

Opportunities Development of novel formulations, Emerging markets expansion, Growth in veterinary health

Key Market Developments:

In 2023, GlaxoSmithKline expanded its donation program for albendazole in partnership with WHO to cover additional countries in Africa.

In 2024, Zoetis launched a new oral dewormer targeting multi-parasitic infestations in pets, offering improved palatability and dosing convenience.

In 2025, Cipla Ltd. introduced a pediatric deworming syrup in the Indian market aimed at enhancing compliance in children.

FAQs:

1. What is the current market size of the Global Anti-worm Medication Market?

The market was valued at USD 2.4 billion in 2023.

2. What is the major growth driver of the Global Anti-worm Medication Market?

The primary growth driver is the rising incidence of parasitic infections globally, especially in developing regions.

3. Which is the largest region during the forecast period in the Global Anti-worm Medication Market?

Asia-Pacific holds the largest market share and is expected to continue its dominance throughout the forecast period.

4. Which segment accounted for the largest market share in the Global Anti-worm Medication Market?

The Broad-spectrum anti-worm medication segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Anti-worm Medication Market?

Key players include GlaxoSmithKline, Johnson & Johnson, Pfizer, Bayer, Sanofi, Cipla, Merck, Zoetis, and Elanco.